KEY TAKEAWAY:“ Programmatic” ad buying typically refers to the use of software to purchase digital advertising, as opposed to the traditional process that involves RFPs, human negotiations and manual insertion orders. It’s using machines to buy ads, basically but it can lead to mistakes for pharma. Continue reading
KEY TAKEAWAY: For those of us who have worked in pharma for many years the term “successful commercialization pharma executive” means one thing; increased sales of a prescription drug. While that is the objective of any prescription drug the means to successful commercialization say a lot about the trouble within our industry.
KEY TAKEAWAY: Until the FDA is serious, along with states, prescription drug pain medications are going to continue to be abused because they are too easy to get hooked on”. Continue reading
KEY TAKEAWAY: Federal investigations of Theranos are ongoing and cover both civil and criminal law. Most companies that have partnered with Thetanos have since terminated their relationship and their CEO, who fancies herself as the Steve Jobs of healthcare, could be barred from the company. Continue reading
KEY TAKEAWAY: Pharma companies can no longer use the excuse of “regulated industry” to keep their distance from patients. They should treat patients like valued customers and do everything they can to help them manage with chronic health problems that interfere with the quality of life as defined by them. Continue reading
Vice President Joe Biden is asking for a cancer moon shot, but is this wishful thinking or the door to a possibility? Cancer is an elusive disease because there are so many different types of cancer, but the VP may just be asking others to dream and to think outside conventional medical wisdom. Continue reading
KEY TAKEAWAY: Within 3 years, 92% of startups failed. Of those who failed 74%, failed due to premature scaling. Premature scaling means spending money on marketing, hiring etc. either before you found a working business model (you acquire users for less than the revenue they bring) or in general spending too fast while failing to secure further financing. Nowhere is more true than in health care startups. Continue reading